TUMOR-ASSOCIATED LOCALIZED SCLERODERMA IN CONJUNCTION WITH ACQIRED DISSIMINATED FORM OF VITILIGO: A CLINICAL CASE

We are presenting the clinical and laboratory case of management of 62 years old patient with combined dermatological tumor-associated diseases: localized form of scleroderma, acquired disseminated form of hypopigmentation (vitiligo). The patient initial visit in a medical dermatological facility was due to the emergence of a consistent following complaints such as the sudden appearance of alterated skin sites in the left breast and some later the occurrence of rushes on the skin on the chest area and on the anterior surface of the abdomen. Upon further examination of the patient have been verified malignant tumor of the left breast, therefore appropriate (complex) treatment have been conducted in a medical institution of oncology service. After 1.5 years after the sectoral mastectomy the patient appealed to the dermatologist again with a complaints to the renewed activity of scleroderma process on the skin of the left breast. On the background of activation of dermatological symptoms the patient have been diagnosed recurrent tumor in the left breast. This clinical case is a multipurpose: first of all, it is demonstrates the importance of the principle of oncological vigilance in multidisciplinary daily medical practice which would improve early diagnosis and, consequently, treatment of the underlying disease; secondly, the present clinical case suggests an unexpected paraneoplastic contour of the diseases which are unpopular in this category previously, but generally frequent in the population.

1. Болотная Л.А., Сербина И.М. Паранеопластические дерматозы. Международный медицинский журнал «Дерматология». 2008; 3: 86-90. Bolotnaya L.A., Serbina I.M. Paraneoplastic dermatoses. The international medical Journal “Dermatology”. 2008; 3: 86- 90.

2. Дворников А.С. Склеродермия как болезнь, ассоциированная со злокачественными заболеваниями. Вестник новых медицинских технологий. 2011; 18(2): 419-420. Dvornikov A.S. Scleroderma as a disease associated with malignant disorders. Herald of new medical technologies. 2011; 18(2): 419-420.

3. Кузнецова Н.П., Чащин А.Ю. К вопросу о паранеоплазиях кожи. Российскй журнал кожных и венерических болезней. 2003; 5: 6-8. Kuznetsova N.P., Chashchin A.Y. To the issue of skin paraneoplastic disorders. Russian Journal of Skin and Venereal Diseases. 2003; 5: 6-8.

4. Мерабишвили В.М. Онкологическая статистика (традиционные методы, новые информационные технологии): Руководство для врачей. Санкт-Петербург. Издание второе, дополненное. Часть I., 2015, 223 с. Merabishvili V.M. The statistics of a cancer (traditional methods, new information technologies): A Guide for Physicians. St. Petersburg. Second Edition, Revised. Part I., 2015, 223 p.

5. Усовецкий И.А., Шарова Н.М., Короткий Н.Г. Комплексный поэтапный метод лечения витилиго у детей и подростков. Педиатрия. 2010; 89(4): 49-54. Usovetskiy I.A., Sharova N.M., Korotkiy N.G. A comprehensive phased treatment of the vitiligo in children and adolescents. Journal of Pediatrics. 2010; 89(4): 49-54.

6. Фицпатрик Д.Е., Эллинг Д.Л. Секреты дерматологии. СПб.: Невский диалект. 1999, 512 с. Fitzpatrick D.E., Elling D.L. Secrets of Dermatology. St. Petersburg: Nevsky Dialect. 1999, 512 p.

7. Черникова Л.И. К вопросу о паранеоплазиях кожи. Актуальные вопросы дерматологи, венерологии и ВИЧ/СПИД инфекции. Сборник научных трудов, посвящен 90-летию со дня рождения профессора Б.А. Задорожного. Под редакцией проф. А.М. Дащука. Харьков. 2013, 3 с. Chernikova L.I. To the issue of skin paraneoplastic disorders. Actual questions of dermatology, Venereology and HIV / AIDS infection. Collection of scientific works, dedicated to the 90th birthday of Professor B.A. Zadorozhny. Edited by prof. A.M. Daschuk. Kharkiv. 2013, 3 p.

8. Шостак Н.А., Дворников А.С., Клименко А.А. и др. Локализованная (очаговая) склеродермия в общей медицинской практике. Лечебное дело. 2015; 4: 45-52. Shostak N.A., Dvornikov A.S., Klimenko A.A. et al. Localized scleroderma in general medical practice. Journal of Medicine. 2015; 4: 45-52.

9. Abu-Shakra M., Buskila D., Ehrenfeld M. et al. Cancer and autoimmunity: autoimmune and rheumatic features in patients with malignancies. Annals of the rheumatic diseases. 2001; 60(5): 433-441.

10. Bonilla-Abadía F., Muñoz-Buitrón E., Ochoa C.D. et al. A rare association of localized scleroderma type morphea, vitiligo, autoimmune hypothyroidism, pneumonitis, autoimmune thrombocytopenic purpura and central nervous system vasculitis. Case report. BMC Res Notes. 2012; 20(5): 689.

11. Dancey A.L., Waters R.A. Morphea of the breast. Two case reports and discussion of the literature. Journal of Plastic Reconstr Aesthet Surg. 2006; 59(10): 1114-1117.

12. Franks A.L., Slansky J.E. Multiple associations between a broad spectrum of autoimmune diseases, chronic inflammatory diseases and cancer. Anticancer research. 2012; 32(4): 1119-1136.

13. Gill L., Zarbo A., Isedeh P., Jacobsen G. et al. Comorbid autoimmune diseases in patients with vitiligo: A cross-sectional study. Journal of the American Academy of Dermatology. 2016; 74(2): 295-302.

14. Joseph C.G., Darrah E., Shah A.A., et al. Association of the autoimmune disease scleroderma with an immunologic response to cancer. Science. 2014; 10(343): 152-157.

15. Reynolds T.D., Knights S.E. Recurrent metastatic breast cancer presenting with paraneoplastic scleroderma. BMJ Case Rep. 2014; doi: 10.1136/bcr-2014-203575.

16. Tomer Y., Sherer Y., Shoenfeld Y. Autoantibodies, autoimmunity and cancer (review). Oncology reports. 1998; 5(3): 753-761.

17. Topal I.O., Gungor S., Kocaturk O.E. et al. Nail abnormalities in patients with vitiligo. Anais brasileiros de dermatologia. 2016; 91(4): 442-445.